CANDICE BLAIR: Open Payments
NPI 1811594146 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,910 in 158 payments from 37 companies in 2025. Trend: 2023 $3,134 · 2024 $2,874 · 2025 $3,910
Food & beverage: $3,810Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $514 |
| Celgene Corporation | 13 | $334 |
| E.R. Squibb & Sons, L.L.C. | 11 | $294 |
| Novartis Pharmaceuticals Corporation | 14 | $252 |
| AstraZeneca Pharmaceuticals LP | 10 | $235 |
| Merck Sharp & Dohme LLC | 8 | $191 |
| PFIZER INC. | 8 | $165 |
| Incyte Corporation | 6 | $163 |
| EMD Serono, Inc. | 7 | $161 |
| Deciphera Pharmaceuticals Inc. | 5 | $119 |
Products named: REBLOZYL, KEYTRUDA, TALVEY, ERLEADA, OPDIVO, BREYANZI, RYBREVANT, QINLOCK.
Industry payments across TN — which companies pay providers there.
